552
R. V. Stick and A. G. Watts
64.59, 70.67 ꢀC4,5), 68.75 ꢀd, J3,F 17 Hz, C3), 85.98 ꢀdd, J2,F 182, J2,P 12 Hz, C2), 95.19 ꢀdd,
J1,F, J1,P 6.0, 32 Hz, Cl), 119.90±150.11 ꢀ12C, Ph) ppm.
2-Deoxy-2-¯uoro-ꢁ-D-mannopyranosyl-bis,tributylammonium) phosphate ꢀC30H66FN2O8P)
PtO2 ꢀ40 mg) was added to a solution of diphenyl 3,4,6-tri-O-acetyl-2-deoxy-2-¯uoro-ꢁ-D-mannosyl
phosphate ꢀ400 mg) in MeOH ꢀ15 cm3), and the mixture was stirred vigorously under an atmosphere
of H2 at room temperature ꢀ2 d). The mixture was ®ltered, diluted with H2O ꢀ2 cm3) and Et3N
ꢀ2 cm3), and the solution was left to stand at 4ꢀC overnight. The mixture was concentrated in vacuo,
taken up in H2O ꢀ5 cm3), and passed through a column of Dowex 50 W-X8 ꢀH ) resin into a vig-
orously stirred mixture of H2O and excess tributylamine. Concentration in vacuo and subsequent
lyophilization gave the title phosphate as a white powder ꢀ416 mg).
1H NMR ꢀ300 MHz, D2O): ꢂ 0.72 ꢀt, 18H, CH3), 1.10±1.21, 1.35±1.51 ꢀ2m, 24H, CH2), 2.85±
2.98 ꢀm, 12H, CH2N), 3.48±3.69 ꢀm, 4H, H4,5,6), 3.76 ꢀddd, J3,F 30.8, J2,3 2.5, J3,4 9.6 Hz,
H3), 4.59 ꢀbddd, J2,F 48.7, J1,2 2.4 Hz, H2), 5.38 ꢀddd, J1,P, J1,F 6.0, 8.1 Hz, H1) ppm; 13C
NMR ꢀ75.5 MHz, D2O): ꢂ 24.05 ꢀ6C, CH3), 30.52, 36.66 ꢀ12C, CH2), 63.89 ꢀ6C, CH2N), 71.57
ꢀC6), 77.62, 84.66 ꢀC4,5), 80.40 ꢀd, J3,F 17.3 Hz, C3), 100.97 ꢀdd, J2,F 174.4, J2,P 9.2 Hz, C2),
104.18 ꢀdd, J1,F 4.5, J1,P 30.6 Hz, C1) ppm.
Uridine 50-,trihydrogendiphosphate), P0-,2-deoxy-2-¯uoro-ꢁ-D-glucopyranosyl) ester
ꢀC15H23FN2O16P2)
Diꢀcyclohexylammonium) 2-deoxy-2-¯uoro-ꢁ-D-glucopyranosyl phosphate ꢀ370 mg, 803 ꢃmol)
was dissolved in H2O ꢀ5 cm3) and passed through a column of Dowex 50 W-X8 ꢀH ) resin into a
vigorously stirred mixture of H2O and excess tributylamine. The eluent was then concentrated
in vacuo, coevaporated with MeOH ꢀ2Â 10 cm3), and dried under high vacuum ꢀ2 d) to give the
bisꢀtributylammonium) salt ꢀ410 mg).
1H NMR ꢀ300 MHz, D2O): ꢂ 0.72 ꢀt, 18H, CH3), 1.07±1.16, 1.25±1.37 ꢀ2m, 24H, CH2), 2.89±
2.93 ꢀm, 12H, CH2N), 3.29 ꢀt, J3,4 ꢁ J4,5 9.9 Hz, H4), 3.56 ꢀdd, J5,6 4.8, J6,6 12.3 Hz, H6),
3.63±3.69 ꢀm, H5,6), 3.80 ꢀdt, J2,3 9.6, J3,F 13.1 Hz, H3), 4.21 ꢀdddd, J1,2, J1,P 2.3, 3.7,
J2,F 49.4 Hz, H2), 6.13 ꢀdd, J1,P 6.6 Hz, H1) ppm; 13C NMR ꢀ125.8 MHz, D2O): ꢂ 15.14 ꢀ6C,
CH3), 21.61, 27.51 ꢀ12C, CH2), 54.96 ꢀ6C, CH2N), 62.52 ꢀC6), 71.15 ꢀd, J4,F 8.3 Hz, C4), 73.37 ꢀd,
J3,F 17.3 Hz, C3), 74.78 ꢀC5), 91.89 ꢀdd, J2,P 6.8, J2,F 187 Hz, C2), 94.25 ꢀdd, J1,P 4.6,
J1,F 22.3 Hz, C1) ppm.
The above bisꢀtributylammonium) salt ꢀ410 mg) and 4-morpholine-N,N0-dicyclohexylcarbox-
amidinium uridine 50-monophosphomorpholidate ꢀ662 mg, 964 ꢃmol) were coevaporated with dry
pyridine ꢀ3 Â 2 cm3). 1H-Tetrazole ꢀ112 mg, 1.61 mmol) and dry pyridine ꢀ4 cm3) were added, and
the solution was then concentrated to half of its original volume and left to stir at room temperature
ꢀ2 d). The solution was then diluted with H2O ꢀ30 cm3), washed with Et2O, and concentrated
in vacuo. The residue was puri®ed on a Bio-Gel P-2 column ꢀ2.5 Â 95 cm) eluting with 250 mM
NH4HCO3 solution and lyophilized to give the title compound as a white powder ꢀ320 mg, 68%).
1H NMR ꢀ500 MHz, D2O): ꢂ 3.34 ꢀt, J3 ;4 ꢁ J4 ;5 9:8 Hz, H400), 3.59 ꢀdd, J5 ;6 4:5,
00 00
00 00
00 00
J6 ;6 12:5 Hz, H600), 3.67 ꢀdd, J5 ;6 2:2 Hz, H600), 3.73 ꢀddd, H500), 3.85 ꢀdt, J2 ;3 9:7, J3 ;F
00 00
00 00
00 00
00
12:8 Hz, H300), 3.97±4.10, 4.16±4.22, 4.27±4.32 ꢀ3m, 6H, H20,30,40,50,200), 5.59 ꢀdd, J1 ;2 3:5,
00 00
J1 ;F 7:3 Hz, H100), 5.77±5.82 ꢀm, H5,10), 7.78 ꢀd, J5,6 8.1 Hz, H6) ppm.
00
Adenosine 50-,trihydrogendiphosphate), P0-,2-deoxy-2-¯uoro-ꢁ-D-glucopyranosyl)
ester ꢀC16H24FN5O14P2)
Following the above procedure, diꢀcyclohexylammonium) 2-deoxy-2-¯uoro-ꢁ-D-glucopyranosyl
phosphate ꢀ285 mg, 618 ꢃmol) was treated with 4-morpholine-N,N0-dicyclohexylcarboxamidinium